Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Cotton

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Acta Neuropsychiatrica|July 1, 2020
Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorderC C Bortolasci, C Voigt, A Turner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up studyR Daglas, S M Cotton, K Allott, et al.
Trials|November 30, 2019
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosisS M Cotton, M Berk, A Watson, et al.
Current Pharmaceutical Design|January 14, 2012
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorderA Bechdolf, A Ratheesh, S J Wood, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Acta Neuropsychiatrica|July 1, 2020
Interleukin-6 and total antioxidant capacity levels following <i>N</i>-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorderC C Bortolasci, C Voigt, A Turner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 15, 2015
A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up studyR Daglas, S M Cotton, K Allott, et al.
Trials|November 30, 2019
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosisS M Cotton, M Berk, A Watson, et al.
Current Pharmaceutical Design|January 14, 2012
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorderA Bechdolf, A Ratheesh, S J Wood, et al.
Pageof 3